Avgerinos, K. I., Ferrucci, L., & Kapogiannis, D. (2021). Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease. Ageing Res Rev.
Citação norma ChicagoAvgerinos, Konstantinos I., Luigi Ferrucci, and Dimitrios Kapogiannis. "Effects of Monoclonal Antibodies against Amyloid-β On Clinical and Biomarker Outcomes and Adverse Event Risks: A Systematic Review and Meta-analysis of Phase III RCTs in Alzheimer’s Disease." Ageing Res Rev 2021.
MLA citiranjeAvgerinos, Konstantinos I., Luigi Ferrucci, and Dimitrios Kapogiannis. "Effects of Monoclonal Antibodies against Amyloid-β On Clinical and Biomarker Outcomes and Adverse Event Risks: A Systematic Review and Meta-analysis of Phase III RCTs in Alzheimer’s Disease." Ageing Res Rev 2021.